SCHEMBL17014349

SCHEMBL17014349

Oc1ccc(I)c2c1C1(CCCC1)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17014371 0.86 BCL2L1 (0.32)
SCHEMBL17014324 0.85 BCL2L1 (0.36)
SCHEMBL17014456 0.81 BCL2L1 (0.36)
SCHEMBL20152961 0.81
SCHEMBL17014350 0.79
SCHEMBL17014494 0.79 BCL2L1 (0.36)
SCHEMBL17014347 0.75 LMNA (0.37)
SCHEMBL17014328 0.73 ALDH1A1 (0.41)
SCHEMBL17014457 0.73 BCL2L1 (0.41)
SCHEMBL17014368 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900656-B1 SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS SUNSHINE LAKE PHARMA CO LTD (CN) 2017-05-17 EP disclosed
US-20150232509-A1 SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS SUNSHINE LAKE PHARMA CO., LTD. (CN) 2015-08-20 US disclosed
US-20150232509-A1 SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS SUNSHINE LAKE PHARMA CO., LTD. (CN) 2015-08-20 US disclosed